There is currently no cure for HIV or AIDs, which makes this disease a really terrifying illness that affects millions of people around the world and kills thousands every year in the U.S. alone. And while the best ways to protect yourself from contracting HIV or AIDs have always been behavioral tactics such as safe sex and not sharing needles, there is currently new research investigating the effectiveness and safety of a new HIV prevention pill with high-risk individuals. And this preventative treatment isn’t just for adults as previously assumed. New studies have found that PrEP therapy for teens is a safe way to reduce the risk of HIV infection among teenagers.
So what is PrEP?
It stands for pre-exposure prophylaxis, and it is a “strategy in which healthy people routinely take one or more antiretroviral drugs to reduce their risk of getting HIV,” according to the National Institute of Allergy and Infectious Disease (NIAID). Currently this treatment is marketed as a single pill called Truvada, which is a combination of two antiretrovirals, tenofovir and emtricitabine that work together to prevent HIV and AIDs.
Keep reading: Page 1 of 3Next